NCT01064869

Brief Summary

Approximately 5% of adults with asthma have difficult to control disease but these account for up to 80% of total cost of asthma due to recurrent healthcare contact including hospital admission. The reasons for "difficult asthma" are multi-factorial, but an important element in many patients is non-adherence to steroid therapy. Recent qualitative analysis by the investigators group has identified a number of both individual and group themes, related to non-adherence with steroid treatment. Many of these themes such as steroid phobia, inaccurate / lack of knowledge, negative attitudes and inability to deal with side-effects, are potentially modifiable and the investigators believe, unless these issues are addressed, at an individual patient level, adherence is unlikely to improve. This randomised parallel group study will examine a nursing intervention to try and improve adherence and as a consequence, asthma control, in a group of difficult asthmatics where non-adherence has been identified as a significant factor. The study will use a needs-led menu driven individualised intervention and will compare this to current best asthma care. The primary outcome measure will be adherence to therapy, however asthma control, lung function and asthma related quality of life, patients' attitudes to asthma and treatment and their levels of anxiety and depression will also be examined. Addressing the issue of non-adherence is fundamental to improving asthma management in this difficult group with concomitant reduction on health care costs and improvements in patients' quality of life

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Jan 2005

Longer than P75 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 9, 2010

Completed
Last Updated

March 15, 2016

Status Verified

March 1, 2016

Enrollment Period

3.9 years

First QC Date

February 8, 2010

Last Update Submit

March 14, 2016

Conditions

Keywords

AdherenceAsthmamedication

Outcome Measures

Primary Outcomes (1)

  • Adherence to Inhaled combination therapy

    6 months

Secondary Outcomes (5)

  • Asthma control score

    6 months

  • Asthma Quality of Life Questionnaire

    6 months

  • Hospital anxiety and depression scale

    6 months

  • Lung function

    6 months

  • Reduction in rescue courses of Steroids

    6 months

Study Arms (2)

Psycho-educational intervention

EXPERIMENTAL

A nurse-led programme of intervention will be devised. Patients will attend weekly for a period of 12 weeks. It will have two stages incorporating: 1\. Structured interview to identify demographic information and individual reasons for non-adherence and assessment of readiness to change behaviour This will be followed by an individualised package incorporating: 1. A structured asthma education programme, to address any gaps in asthma knowledge or requests for information 2. Motivational interviewing based on stages of change model to encourage change and adherence 3. Psychological therapy involving (a) relaxation therapy (b) cognitive behavioural techniques looking at negative and catastrophic thoughts and (c) panic cycle adapted to respiratory patients

Behavioral: Pyscho-behavioural

usual care

NO INTERVENTION

Standard asthma management

Interventions

A nurse-led programme of intervention will be devised. Patients will attend weekly for a period of 12 weeks. It will have two stages incorporating: 1\. Structured interview to identify demographic information and individual reasons for non-adherence and assessment of readiness to change behaviour This will be followed by an individualised package incorporating: 1. A structured asthma education programme, to address any gaps in asthma knowledge or requests for information 2. Motivational interviewing based on stages of change model to encourage change and adherence 3. Psychological therapy involving (a) relaxation therapy (b) cognitive behavioural techniques looking at negative and catastrophic thoughts and (c) panic cycle adapted to respiratory patients

Psycho-educational intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Filling \<50% of prescription refills for inhaled combination therapy
  • Persisting asthma symptoms (ACS \>3) despite detailed assessment and management
  • Minimal maintenance therapy of long acting beta2-agonist and inhaled steroids (800mg BDP or equivalent)
  • At least 1 course of systemic steroids in the preceding 12 months.

You may not qualify if:

  • Medication adherence
  • A condition other than asthma contributing to persisting symptoms
  • Current smoker
  • Ex-smoker \> 10 pack years -Significant co-morbidity due to condition other than asthma.-

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regional Respiratory Centre, Belfast City Hospital

Belfast, Co Down, BT 9 7AB, United Kingdom

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Liam Heaney, MD

    Belfast Health and Social Care Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 8, 2010

First Posted

February 9, 2010

Study Start

January 1, 2005

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

March 15, 2016

Record last verified: 2016-03

Locations